Skip to content
GE HealthCare Technologies logo

GE HealthCare Technologies

GEHC

GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions.

Market cap
$29.42B-15.5%
Revenue$21.0B+6.0%
Net income$1.9B-12.5%
Free cash flow$1.5B-17.2%
EPS (diluted)$4.18-12.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Jul 29, 2026 (In 2 weeks)
Revenue estimate$5.3B
EPS estimate$1.04

Financials

Q1 2026

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation & ratios

Valuation

See full
Market cap$29.42B-15.5%
P/E15.4×-0.1×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Segments

By segment

See full
Imaging$2.3B+7.4%
AVS$1.3B+8.2%
PDx$770.0M+21.8%
PCS$704.0M-6.5%

By product

See full
Service$1.8B+7.6%

Competitors

Profile

GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions. The company focuses on delivering precision care through a combination of hardware, AI-enabled software, and clinical services to help clinicians diagnose and treat complex diseases. Its value proposition centers on integrating diagnostic tools with data-driven insights to improve patient outcomes and operational efficiency for healthcare providers.

Competitive position

A leading global provider with a 130-year history and a massive installed base of connected devices across 160 countries.

GeographiesGlobal, United States, Europe, Emerging Markets
Customer segmentsHospitals, Health systems, Government institutions, Academic researchers
Business modelEquipment sales, Subscription SaaS, Recurring consumables, Maintenance services, Professional services
SuppliersRadioisotope suppliers, Electronic component manufacturers, Raw material suppliers for contrast media, Software developers
CustomersPublic hospitals, Private health systems, Diagnostic laboratories, Clinical research organizations
Listed2022
Employees51.0K
CEOPeter J. Arduini
FilingsSEC EDGAR

Questions, answered.

What is GE HealthCare Technologies's market cap?
GE HealthCare Technologies (GEHC) has a market capitalization of $29.4B and trades on NASDAQ.
What is GE HealthCare Technologies's revenue and profitability?
GE HealthCare Technologies generated $21.0B in trailing twelve-month revenue with net income of $1.9B, representing a net margin of 9.1%. Gross margin stands at 39.1%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.
Who are GE HealthCare Technologies's competitors?
GE HealthCare Technologies's key competitors include Philips Healthcare, RadNet, Inc. Common Stock, Lumexa Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does GE HealthCare Technologies partner with?
GE HealthCare Technologies's notable partners include GE Aerospace.
Where is GE HealthCare Technologies headquartered?
GE HealthCare Technologies is headquartered in United States of America and employs approximately 51,000 people. It has been publicly traded since 2022.